Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk

NCT01720225 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

113

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Decitabine
DRUG: Azacitidine

Sponsor

M.D. Anderson Cancer Center